Cargando…
AB041. Evolution of PDE5 inhibitors in Korea
After launching of Sildenafil Citrate, the last invention of 20(th) century, in 1998, oral PDE5 inhibitor has been established as first line treatment of erectile dysfunction (ED) and shift new paradigm of diagnosis and treatment of ED. The big success of sildenafil in pharmaceutical R&D induced...
Autor principal: | Moon, Du Geon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708683/ http://dx.doi.org/10.3978/j.issn.2223-4683.2015.s041 |
Ejemplares similares
-
AB030. Evolution of phosphodiesterase type 5 inhibitors
por: Moon, Du Geon
Publicado: (2016) -
AB041. Perioperative nursing care of penile pacemaker implantation
por: Han, Di
Publicado: (2017) -
AB041. Experience in the use of collagenase clostridium histolyticum in the management of Peyronie’s disease
por: Jad, Amr, et al.
Publicado: (2016) -
AB020. Penile rehabilitation with PDE5 inhibitors in men following radical prostatectomy
por: Jiann, Bang-Ping
Publicado: (2015) -
AB51. PDE5 expression in the prostate: where is it really?
por: Lin, Ching-Shwun
Publicado: (2014)